Menu

One Case Closes, Another Opens

Unsure of the origins of a rogue crop found on an Oregon farm, the US Department of Agriculture is following up on a second issue related to genetically engineered wheat.

Sep 29, 2014
Tracy Vence

WIKIMEDIA, DAVID MONNIAUXAfter months of investigation, the United States Department of Agriculture (USDA) has closed the case of the genetically engineered (GE) wheat an Oregon farmer mysteriously found growing in his fields last year. In a September 26 statement, the USDA Animal and Plant Health Inspection Service (APHIS) said it had “concluded that the presence of the GE wheat”—a variety called Roundup Ready, produced by Monsanto to be resistant to its herbicide Roundup—“appears to be an isolated incident.” In its investigation, the agency found no evidence that the modified wheat had entered the marketplace—a finding APHIS said was “critical . . . to trading partners to keep foreign wheat markets open.”

How the plant arrived on the farm remains a mystery, however. “After exhausting all leads, APHIS was unable to determine exactly how the GE wheat came to grow in the farmer’s field,” the agency said.

The agency added that it’s now investigating the appearance of GE wheat at Montana State University’s Southern Agricultural Research Center, where the crop was grown as part of government-approved field trials from 2000 to 2003. APHIS said the appearance of Monsanto’s Roundup Ready wheat in the two states were isolated incidents.

Hat tip: NPR’s The Salt

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.